MRK vs TECH
By Alex · Tickerpine
Merck & Company, Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TECH |
|---|---|---|
| Price | $132.92 | $72.23 |
| Market cap | $327.94B | $11.25B |
| P/E ratio | 106.3 | 103.2 |
| ROE | 6.96% | 5.34% |
| Profit margin | 4.77% | 9.05% |
| Revenue growth | 5.10% | -1.50% |
| Dividend yield | 2.56% | 0.44% |
| Beta | 0.21 | 1.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TECH in plain English
- MRK is the bigger company — about 29.1× the market cap of TECH.
- TECH is cheaper on earnings (P/E 103.2 vs 106.3).
- MRK earns a higher return on equity (7% vs 5%).
- MRK is growing revenue faster (5% vs -2%).
- MRK has the higher dividend yield (2.56% vs 0.44%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.